Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2007 Jan;44(1):1-9.
doi: 10.1136/jmg.2006.043257. Epub 2006 Jul 6.

Clinical and molecular features associated with biallelic mutations in FANCD1/BRCA2

Affiliations

Clinical and molecular features associated with biallelic mutations in FANCD1/BRCA2

Blanche P Alter et al. J Med Genet. 2007 Jan.

Abstract

Patients with biallelic mutations in BRCA2 are in Fanconi anaemia group D1. We analysed the severity of the mutations in 27 cases, classified according to their association with breast cancer in heterozygotes, and their predicted functional effect. Twenty mutations were frameshifts or truncations, three involved splice sites, five were missense variants of unknown severity and two were benign polymorphisms. Five patients had VACTERL-H association. Leukaemia was reported in 13 patients, and solid tumours in 15; 6 patients had two or more malignancies. The cumulative probability of any malignancy was 97% by age 5.2 years. IVS7+1G-->A and IVS7+2T-->G were associated with AML, and 886delGT and 6174delT with brain tumours. However, patients with other alleles remained at very high risk of these events. Missense mutations formed a distinct cluster in a highly conserved region of the BRCA2 protein. The small group of patients with biallelic mutations in BRCA2 is distinctive in the severity of the phenotype, and early onset and high rates of leukaemia and specific solid tumours, and may comprise an extreme variant of Fanconi anaemia. Several of the alleles were not associated with cancer in presumed carriers, and thus counselling presents more uncertainties than usual.

PubMed Disclaimer

Conflict of interest statement

Competing interests: None declared.

Similar articles

Cited by

References

    1. Alter B P. Inherited bone marrow failure syndromes. In: Nathan DG, Orkin SH, Look AT, Ginsburg D, eds. Nathan and Oski's Hematology of Infancy and Childhood, 6th edn. Philadelphia, PA: WB Saunders, 2003280–365.
    1. Taniguchi T, D'Andrea A D. The molecular pathogenesis of Fanconi anemia: recent progress. Blood 20061074223–4233. - PubMed
    1. Kennedy R D, D'Andrea A D. The Fanconi Anemia/BRCA pathway: new faces in the crowd. Genes Dev 2005192925–2940. - PubMed
    1. Ford D, Easton D F, Stratton M, Narod S, Goldgar D, Devilee P, Bishop D T, Weber B, Lenoir G, Chang‐Claude J, Sobol H, Teare M D, Struewing J, Arason A, Scherneck S, Peto J, Rebbeck T R, Tonin P, Neuhausen S, Barkardottir R, Eyfjord J, Lynch H, Ponder B A, Gayther S A, Zelada‐Hedman M. Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium. Am J Hum Genet 199862676–689. - PMC - PubMed
    1. The Breast Cancer Linkage Consortium Cancer risks in BRCA2 mutation carriers. J Natl Cancer Inst 1999911310–1316. - PubMed

Publication types